RespireRx Pharmaceuticals Inc (fka RSPI)

[neuroinv]

I am absolutely certain that the financial incentives for RD2 had nothing to do with preparing a package for a PIPE. Earlier completion did allow them to at least sow the seeds for partnership discussions once summer has ended. But it would be a mistake to disregard how seriously Stoll takes keeping his promises, and his awareness that Cortex shareholders have learned to be skeptical based on past unpleasant surprises--and not wanting to again leave them feeling that Cortex had not delivered. To the degree to which timeliness was under his control (and financial incentives are the only lever they had), he was going to try to meet the end of July timeframe he'd set. With financial incentives not feasible for RD1 due to the academic setting, he didn't have the same control there.

NeuroInvestment